Ontario reports first blood clot death in AstraZeneca vax recipient
Ontario is reporting its first death associated with a rare blood clotting disorder linked to the Oxford-AstraZeneca vaccine.
The province's associate medical officer of health announced the death today.
Dr. Barbara Yaffe says the man in his 40s received a first dose of the AstraZeneca vaccine at the end of April.
She says he passed away a few weeks later.
Yaffe says it's been confirmed that the man had vaccine-induced immune thrombotic thrombocytopenia, also known as VITT, at the time.
Nearly one million people in Ontario aged 40 and older have received the AstraZeneca vaccine.